Celularity Appoints Paul Graves as Chief Communications Officer -…
FLORHAM PARK, NJ, Jan. 04, 2023 (GLOBE NEWSWIRE) — Celularity Inc. CELU (“Celularity”), a biotechnology company developing placenta-derived allogeneic cell and biomaterial therapies, today announced